CareCloud, Inc. filings document operating results, Regulation FD presentation materials, governance actions, and capital-structure disclosures for a healthcare technology and revenue cycle management company. The records cover common stock, preferred-stock dividend and security matters, credit facility events, and formal updates tied to financial performance.
CareCloud’s proxy and current reports also disclose shareholder voting matters, bylaw amendments, board and audit committee composition, Nasdaq compliance items, and cybersecurity incident reporting. These filings frame the company’s Healthcare IT and Medical Practice Management activities alongside risk, governance, and public-company reporting obligations.
CareCloud, Inc. Chief Executive Officer Stephen Andrew Snyder reported a disposition of 30,790 shares of the company’s Series B Cumulative Redeemable Perpetual Preferred Stock. The shares were removed from his direct holdings at a price of $25.25 per share, leaving him with zero shares of this preferred series.
According to the disclosure, this transaction was carried out through a mandatory redemption of the Series B Preferred Stock by the issuer and was not an open market sale initiated by Snyder.
CareCloud, Inc. interim CFO and Controller Norman Roth reported a mandatory redemption of 6,500 shares of the company’s Series B Cumulative Redeemable Perpetual Preferred Stock. The shares were disposed of at $25.25 per share in a transaction classified as a disposition to the issuer, not an open market sale, leaving no remaining holdings of this preferred security.
CareCloud, Inc. director Bill Korn reported a disposition of 10,800 shares of the company’s Series B Cumulative Redeemable Perpetual Preferred Stock. The shares were transferred back to the issuer at $25.25 per share through a mandatory redemption, and his reported holdings of this preferred stock are now zero.
The transaction was characterized as a disposition to the issuer rather than an open market sale, indicating the redemption was driven by the security’s terms rather than an individual trading decision.
CareCloud, Inc. Chief Strategy Officer A Hadi Chaudhry reported a mandatory redemption of 7,800 shares of Series B Cumulative Redeemable Perpetual Preferred Stock at $25.25 per share. The shares were disposed of back to the issuer, and the reporting person now holds 0 shares of this security.
CareCloud, Inc. has fully redeemed and delisted its 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock. On May 15, 2026, the company paid a Redemption Price of $27.52 per share, for an aggregate of approximately $41.6 million, including all accumulated and unpaid dividends.
The Series B Preferred Stock was delisted from the Nasdaq Global Market as of the close of business on May 14, 2026 following the company’s request for a Form 25 to remove it from listing and registration. All preferred holders have been paid in full, no Series B shares remain outstanding, and holders’ ongoing rights are limited to receiving the Redemption Price. The company’s common stock continues to trade on Nasdaq under the ticker “CCLD.”
CareCloud, Inc. notified the removal of its 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock from listing and registration on the Nasdaq Stock Market LLC. Nasdaq certified it has complied with 17 CFR 240.12d2-2 and the issuer confirmed compliance with the Exchange's voluntary withdrawal requirements.
CareCloud, Inc. notified the removal and voluntary withdrawal of its 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock from listing and registration on the Nasdaq Stock Market LLC. The Exchange and the issuer each certified compliance with the applicable 17 CFR 240.12d2-2 procedures for delisting and withdrawal.
CareCloud, Inc. reported first-quarter 2026 net revenue of $31.3 million, up from $27.6 million a year earlier, driven mainly by technology-enabled business solutions and recent acquisitions such as Medsphere, RevNu and MAP App. Healthcare IT contributed $27.5 million and Medical Practice Management $3.8 million of revenue.
Net income was $0.9 million versus $1.9 million in 2025 as operating expenses, including higher general and administrative and research and development costs, grew faster than revenue. After $1.4 million of preferred dividends, common shareholders recorded a $0.4 million net loss, or $(0.01) per share. Operating cash flow was $3.6 million. During the quarter, CareCloud continued integrating acquisitions, carried $31.4 million of goodwill and $16.5 million of net intangibles, and disclosed a March 2026 cybersecurity incident affecting one electronic health record environment, which is under forensic review and has prompted class action complaints from certain patients.
CareCloud, Inc. reported Q1 2026 revenue of $31.3 million, up from $27.6 million in Q1 2025, a 13% year-over-year increase. GAAP net income was $0.9 million, down from $1.9 million a year ago, while adjusted EBITDA was $5.4 million versus $5.6 million.
The company reaffirmed its full-year 2026 guidance, targeting revenue of $128–$132 million, adjusted EBITDA of $29–$31 million, and GAAP EPS of $0.20–$0.23, compared to $0.10 in 2025. Management highlighted a new $50 million credit facility, the announced full cash redemption of all Series B Preferred Stock on May 15, 2026, and AI product launches, including stratusAI Desk Agent automating roughly 75% of inbound calls.
CareCloud, Inc. intends to sell up to $60,000,000 of common stock through an At-The-Market offering under an At The Market Offering Agreement dated April 13, 2026 with Citizens JMP Securities, LLC. Sales may occur from time to time on the Nasdaq or in other permitted transaction types as an “at-the-market offering.” The placement agent fee is 3.0% of gross proceeds and Citizens will be deemed an underwriter for Securities Act purposes. Net proceeds, if any, will be used for working capital and general corporate purposes, which may include acquisitions, debt repayment, capital expenditures and redemption of preferred stock.